Bastianetto S, Zheng W H, Quirion R
Department of Psychiatry, Pharmacology and Therapeutics, Douglas Hospital Research Centre, McGill University, 6875 Bld LaSalle, Verdun, Québec, H4H 1R3 Canada.
Br J Pharmacol. 2000 Oct;131(4):711-20. doi: 10.1038/sj.bjp.0703626.
Animal and epidemiological studies suggest that polyphenol constituents of red wine possess antioxidant activities that favour protection against cardiovascular disease - the so-called. 'French paradox' - and possibly, central nervous system disorders such as Alzheimer's disease (AD) and ischaemia. In the present study, the potential of three major red wine derived-polyphenols to protect against toxicity induced by the nitric oxide free radical donors sodium nitroprusside (SNP) and 3-morpholinosydnonimine (SIN-1) was examined in cultured rat hippocampal cells. Both co- and post-treatments with either the stilbene resveratrol (5 - 25 microM) or the flavonoids quercetin (5 - 25 microM) and (+)-catechin (1 - 10 microM) were capable of attenuating hippocampal cell death and intracellular reactive oxygen species accumulation produced by SNP (100 microM and 1 mM, respectively). However, among the phenolic compounds tested, only the flavonoids afforded significant protection against 5 mM SIN-1-induced toxicity. The effects of phenolic constituents were shared by Trolox (100 microM), a vitamin E analogue, but not by selective inhibitors of cyclo-oxygenases (COX) and lipoxygenases (LOX). Among the phenolic compounds tested, only quercetin (10 microM) inhibited 100 microM SNP-stimulated protein kinase C (PKC) activation, whereas none of them were able to attenuate nitrite accumulation caused by SNP (100 microM). Taken together, these data suggest that the neuroprotective abilities of quercetin, resveratrol, and (+)-catechin result from their antioxidant properties rather than their purported inhibitory effects on intracellular enzymes such as COX, LOX, or nitric oxide synthase. Quercetin, however, may also act via PKC to produce its protective effects.
动物和流行病学研究表明,红酒中的多酚成分具有抗氧化活性,有助于预防心血管疾病——即所谓的“法国悖论”——并且可能预防中枢神经系统疾病,如阿尔茨海默病(AD)和局部缺血。在本研究中,检测了三种主要的红酒衍生多酚对一氧化氮自由基供体硝普钠(SNP)和3-吗啉代-sydnonimine(SIN-1)诱导的毒性的保护潜力。在用二苯乙烯白藜芦醇(5 - 25微摩尔)或类黄酮槲皮素(5 - 25微摩尔)和(+)-儿茶素(1 - 10微摩尔)进行共处理和后处理时,均能够减轻SNP(分别为100微摩尔和1毫摩尔)产生的海马细胞死亡和细胞内活性氧积累。然而,在所测试的酚类化合物中,只有类黄酮对5毫摩尔SIN-1诱导的毒性提供了显著保护。酚类成分的作用与维生素E类似物Trolox(100微摩尔)相同,但环氧化酶(COX)和脂氧化酶(LOX)的选择性抑制剂则没有这种作用。在所测试的酚类化合物中,只有槲皮素(10微摩尔)抑制了100微摩尔SNP刺激的蛋白激酶C(PKC)激活,而它们均不能减轻SNP(100微摩尔)引起的亚硝酸盐积累。综上所述,这些数据表明,槲皮素、白藜芦醇和(+)-儿茶素的神经保护能力源于它们的抗氧化特性,而不是它们对细胞内酶如COX、LOX或一氧化氮合酶的所谓抑制作用。然而,槲皮素也可能通过PKC发挥作用以产生其保护作用。